Section one: Contracting authority
one.1) Name and addresses
NHS Norfolk & Waveney Integrated Care Board
County Hall, Martineau Ln
Norwich
NR1 2DH
Country
United Kingdom
Region code
UKH15 - Norwich and East Norfolk
Internet address(es)
Main address
https://www.improvinglivesnw.org.uk/about-us/our-nhs-integrated-care-board-icb/icb-contact/
Buyer's address
https://www.improvinglivesnw.org.uk/about-us/our-nhs-integrated-care-board-icb/icb-contact/
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Provision of Hypertension and Lipids Optimisation Project
Reference number
Nw2025-89
two.1.2) Main CPV code
- 85100000 - Health services
two.1.3) Type of contract
Services
two.1.4) Short description
This is a notice to inform the market the procurement has been abandoned.
NHS Norfolk and Waveney Integrated Care Board sought to procure a Hypertension and Lipids Optimisation Project. The successful provider staff was expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.
NHS Norfolk and Waveney Integrated Care Board sought to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.
The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.
The successful provider is was expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.
Prescribers must be able to initiate relevant medicines.
Prescribers must initiate medicines in line with N&W criteria.
Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.
Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.
The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 85323000 - Community health services
- 85141000 - Services provided by medical personnel
- 85140000 - Miscellaneous health services
two.2.3) Place of performance
NUTS codes
- UKH1 - East Anglia
two.2.4) Description of the procurement
This is a notice to inform the market the procurement has been abandoned.
NHS Norfolk and Waveney Integrated Care Board sought to procure a Hypertension and Lipids Optimisation Project. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.
This was a 1 year contract with the option to extend for up to an additional 2 years. The 1 year contract value is a a maximum of £200,000. Any additional extensions are estimated to be £200,000 per annum a maximum contract value of £600,000 over the full 3 year contract period.
Service Description:
NHS Norfolk and Waveney Integrated Care Board sought to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.
The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.
The successful provider was expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.
Prescribers must be able to initiate relevant medicines.
Prescribers must initiate medicines in line with N&W criteria.
Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.
Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.
The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.
two.2.5) Award criteria
Quality criterion - Name: Quality and Innovation / Weighting: 55
Cost criterion - Name: value / Weighting: 0
Cost criterion - Name: Integration, Collaboration and Service Sustainability / Weighting: 23
Cost criterion - Name: Improving Access, Reducing Health Inequalities and Facilitating Choice / Weighting: 12
Cost criterion - Name: Social Value / Weighting: 10
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2025/S 000-009953
Section five. Award of contract
A contract/lot is awarded: No
five.1) Information on non-award
The contract/lot is not awarded
Other reasons (discontinuation of procedure)
Section six. Complementary information
six.3) Additional information
The Commissioners made a decision to abandon the current process as permitted within Document 1 – ITT Process Overview document. The justification was that the Commissioners requirements have changed and with recent announcement regarding future Commissioning Landscape, the Commissioners are withdrawing this process and intend to go back to out to market with a new service offer including revised documentation.
six.4) Procedures for review
six.4.1) Review body
NHS England
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
england.commercialqueries@nhs.net
Country
United Kingdom